ジメチルホルムアミド（DMF）市場 - 世界の産業規模、シェア、動向、機会、予測：タイプ別、エンドユーザー別、地域別、競合、2020年～2030年

ジメチルホルムアミド（DMF）の世界市場は、2024年に25億3,000万米ドルと評価され、2030年には29億7,000万米ドルに達し、CAGRで2.84%の成長が予測されています。

ジメチルホルムアミド（DMF）は広く使用されている無色の有機溶媒で、工業用途や化学用途に汎用性があることで知られています。化学的に（CH3）2NC（O）Hと表されるDMFは、高沸点の親水性非プロトン性溶媒として機能し、SN2機構などの極性反応を促進するのに理想的です。水や様々な有機化合物と結合すると均一な混合物を形成するため、化学合成において広く使用されています。DMFは主にギ酸とジメチルアミンの反応によって生成されます。しかし、強酸や強塩基にさらされると化学的に不安定になり、ギ酸とジメチルアミンに加水分解されます。DMFは水溶性が高く、有機物であり、蒸発速度が遅いため、様々な産業分野で好まれている溶媒です。

DMFは工業的に重要であるにもかかわらず、健康面や安全面で大きな懸念があり、市場力学に影響を及ぼしています。調査により、DMFへの暴露は発がん性の影響や先天性障害の可能性が指摘されており、特定の地域では規制上の制限、特にDMFを扱う職場での女性の暴露制限につながっています。国際がん研究機関（IARC）はDMFを発がん性物質の可能性があると分類しているが、米国環境保護庁（EPA）は決定的な発がんリスクとはみなしていないです。それにもかかわらず、EPAの報告によれば、DMFへの急性暴露は肝不全を含む深刻な健康問題を引き起こす可能性があり、これはDMFの市場受容と成長にとって重大な課題となっています。その結果、多くの産業が健康リスクを軽減するため、ジメチルスルホキシド（DMSO）などのより安全な代替品にシフトしています。

主な市場促進要因

製薬業界からのジメチルホルムアミド（DMF）需要の高まり

主な市場課題

原材料コストの変動

主要市場動向

高純度DMFの需要拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のジメチルホルムアミド（DMF）市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェア・予測
  • タイプ別（反応物質、原料）
  • エンドユーザー別（化学、エレクトロニクス、医薬品、農業）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域のジメチルホルムアミド（DMF）市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェア・予測
  • タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のジメチルホルムアミド（DMF）市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のジメチルホルムアミド（DMF）市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のジメチルホルムアミド（DMF）市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのジメチルホルムアミド（DMF）市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界のジメチルホルムアミド（DMF）市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• BASF SE
• Balaji Amines Ltd.
• Bell Chem Corp
• Methanol Chemicals Co.
• Eastman Chemical Company
• Jiutian Chemical Group Ltd.
• Luxi Group Co Ltd
• Mitsubishi Gas Chemical Company Inc.
• PON Pure Chemical India Pvt Ltd
• Shandong Hualu-Hengsheng Chemical Co., Ltd.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Dimethylformamide Market was valued at USD 2.53 Billion in 2024 and is expected to reach USD 2.97 Billion by 2030 with a CAGR of 2.84%. Dimethylformamide (DMF) is a widely used, colorless organic solvent known for its versatility in industrial and chemical applications. Chemically represented as (CH3)2NC(O)H, DMF serves as a hydrophilic aprotic solvent with a high boiling point, making it ideal for facilitating polar reactions such as SN2 mechanisms. It forms homogeneous mixtures when combined with water and various organic compounds, contributing to its widespread use in chemical synthesis. DMF is primarily produced through the reaction of formic acid and dimethylamine. However, it is chemically unstable when exposed to strong acids or bases, undergoing hydrolysis into formic acid and dimethylamine. Due to its high water solubility, organic nature, and slow evaporation rate, DMF remains a preferred solvent across multiple industrial sectors.

Despite its industrial importance, DMF poses significant health and safety concerns that affect market dynamics. Research has linked DMF exposure to potential carcinogenic effects and suspected congenital disabilities, leading to regulatory restrictions in certain regions, particularly limiting women's exposure in workplaces handling DMF. While the International Agency for Research on Cancer (IARC) classifies DMF as a possible carcinogen, the U.S. Environmental Protection Agency (EPA) does not consider it a definitive cancer risk. Nonetheless, acute exposure to DMF can cause severe health issues, including liver failure, as reported by the EPA, which represents a critical challenge to its market acceptance and growth. Consequently, many industries are shifting toward safer alternatives, such as dimethyl sulfoxide (DMSO), to mitigate health risks.

Key Market Drivers

Growing Demand of Dimethylformamide from Pharmaceutical Industry

Dimethylformamide (DMF) is a critical organic solvent extensively used in the pharmaceutical industry, playing a vital role in the manufacturing of various drugs, including antibiotics, antivirals, and pharmaceutical adjuvants. Its widespread adoption stems from its superior solvent capabilities, excellent chemical stability, and low evaporation rate, making it essential in numerous drug production processes. India's pharmaceutical industry, valued at approximately USD 58 billion currently, is expected to expand significantly, reaching USD 125 billion by 2030 and USD 425 billion by 2047. This rapid growth in the pharmaceutical sector is a key driver for the dimethylformamide (DMF) market, as DMF is widely used as a critical solvent in drug manufacturing. The industry's expansion will increase demand for DMF, supporting its market growth and encouraging further innovation and production to meet evolving pharmaceutical needs.

The pharmaceutical sector's rapid growth, driven by global health challenges and increased drug demand, has significantly boosted the market for DMF. This rising demand has prompted manufacturers to focus on enhancing the quality and efficiency of DMF to better meet the evolving requirements of pharmaceutical production. Beyond its traditional applications, DMF is increasingly utilized in innovative pharmaceutical technologies, such as advanced drug delivery systems, expanding its scope and value within the industry. This diversification underscores DMF's adaptability and its critical contribution to pharmaceutical innovation.

As the global pharmaceutical market continues to expand, propelled by the development of new drugs and cutting-edge delivery methods, the demand for DMF is projected to grow correspondingly. Manufacturers are expected to invest further in research and development to improve DMF formulations, ensuring compliance with stringent quality standards and supporting the pharmaceutical industry's dynamic needs. The pharmaceutical industry represents a key growth driver for the global DMF market. The sector's ongoing expansion and innovation are expected to sustain and accelerate demand for DMF, reinforcing its strategic importance. As pharmaceutical companies continue to develop novel therapies and delivery platforms, DMF will remain an indispensable solvent, underpinning the future growth and evolution of the global DMF market.

Key Market Challenges

Volatility in Cost of Raw Materials

DMF (Dimethylformamide) is a versatile organic compound extensively used as a solvent in various industries, including pharmaceuticals, agriculture, and chemical production. Its widespread application stems from its excellent solvency properties and compatibility with different substances. However, the production of DMF is not without its complexities.

The manufacturing process of DMF involves the utilization of several raw materials, each of which contributes to the overall cost of production. These raw materials are subject to market dynamics and can experience fluctuations due to various factors, such as supply disruptions, demand spikes, and trade restrictions. The volatility in raw material prices adds an additional layer of complexity to the DMF market.

In recent times, the DMF market has witnessed a sustained decline in price trends. This downward trajectory can be partly attributed to the weak methanol prices and a steady demand from downstream industries. While this may seem beneficial for manufacturers in the short term, it introduces a level of unpredictability that can make long-term planning and investment decisions challenging.

Fluctuating raw material costs can significantly impact manufacturers' profit margins. When these costs rise, manufacturers are faced with a difficult choice - either absorb the increased costs, resulting in reduced profits, or pass them onto customers, potentially leading to a decrease in demand. Such market dynamics can create a delicate balance for manufacturers to maintain their competitiveness while ensuring sustainable profitability.

Key Market Trends

Growing Demand of High-Purity DMF

High-purity DMF, a refined version of the organic compound, is extensively used as a solvent and reagent in the pharmaceutical industry. Its exceptional properties, including high solvent power, excellent chemical stability, and low evaporation rate, make it a vital component in the manufacture of various drugs. From antibiotics to antiviral medications and pharmaceutical adjuvants, high-purity DMF plays a crucial role in ensuring the purity and efficacy of these pharmaceutical products.

The pharmaceutical sector's preference for high-purity DMF stems from its ability to maintain strict purity levels, preventing contamination that could compromise the quality of drugs. As the demand for pharmaceuticals surges, especially in the face of the ongoing global health crisis, the need for high-purity DMF has significantly increased. This growing demand is driving the growth of the DMF market, as manufacturers strive to meet the requirements of the expanding pharmaceutical industry.

The growing demand for high-purity dimethylformamide from the pharmaceutical industry represents a major trend in the global DMF market. As the pharmaceutical sector continues to expand and evolve, this trend is expected to play an even more significant role in shaping the future of the DMF market. The critical role of high-purity DMF in drug manufacturing processes underscores its importance in ensuring the safety and efficacy of pharmaceutical products, making it an indispensable component in the pharmaceutical industry's pursuit of innovation and excellence.

Key Market Players

• BASF SE
• Balaji Amines Ltd.
• Bell Chem Corp
• Methanol Chemicals Co.
• Eastman Chemical Company
• Jiutian Chemical Group Ltd.
• Luxi Group Co Ltd
• Mitsubishi Gas Chemical Company Inc.
• PON Pure Chemical India Pvt Ltd
• Shandong Hualu-Hengsheng Chemical Co., Ltd.

Report Scope:

In this report, the Global Dimethylformamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dimethylformamide Market, By Type:

• Reactant
• Feedstock

Dimethylformamide Market, By End User:

• Chemical
• Electronics
• Pharmaceutical
• Agriculture

Dimethylformamide Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dimethylformamide Market.

Available Customizations:

Global Dimethylformamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Dimethylformamide Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value & Volume
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Reactant, Feedstock)
  • 4.2.2. By End User (Chemical, Electronics, Pharmaceutical, Agriculture)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By End User
  • 4.3.3. By Region

5. Asia Pacific Dimethylformamide Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By End User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Dimethylformamide Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value & Volume
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By End User
  • 5.3.2. India Dimethylformamide Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value & Volume
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By End User
  • 5.3.3. Australia Dimethylformamide Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value & Volume
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By End User
  • 5.3.4. Japan Dimethylformamide Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value & Volume
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By End User
  • 5.3.5. South Korea Dimethylformamide Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value & Volume
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By End User

6. Europe Dimethylformamide Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Dimethylformamide Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value & Volume
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Germany Dimethylformamide Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value & Volume
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Spain Dimethylformamide Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value & Volume
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User
  • 6.3.4. Italy Dimethylformamide Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value & Volume
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By End User
  • 6.3.5. United Kingdom Dimethylformamide Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value & Volume
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By End User

7. North America Dimethylformamide Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Dimethylformamide Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value & Volume
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Mexico Dimethylformamide Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value & Volume
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Canada Dimethylformamide Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value & Volume
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User

8. South America Dimethylformamide Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Dimethylformamide Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value & Volume
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Argentina Dimethylformamide Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value & Volume
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Colombia Dimethylformamide Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value & Volume
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User

9. Middle East and Africa Dimethylformamide Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Dimethylformamide Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value & Volume
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Saudi Arabia Dimethylformamide Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value & Volume
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. UAE Dimethylformamide Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value & Volume
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User
  • 9.3.4. Egypt Dimethylformamide Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value & Volume
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Dimethylformamide Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. BASF SE
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Balaji Amines Ltd.
• 14.3. Bell Chem Corp
• 14.4. Methanol Chemicals Co.
• 14.5. Eastman Chemical Company
• 14.6. Jiutian Chemical Group Ltd.
• 14.7. Luxi Group Co Ltd
• 14.8. Mitsubishi Gas Chemical Company Inc.
• 14.9. PON Pure Chemical India Pvt Ltd
• 14.10. Shandong Hualu-Hengsheng Chemical Co., Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer